BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33565601)

  • 1. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.
    Díaz Del Arco C; Ortega Medina L; Estrada Muñoz L; García Gómez de Las Heras S; Fernández Aceñero MJ
    Histol Histopathol; 2021 Jun; 36(6):587-613. PubMed ID: 33565601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Molina Roldán E; Cerón Nieto MÁ; García Gómez de Las Heras S; Fernández Aceñero MJ
    World J Gastrointest Oncol; 2022 Jun; 14(6):1162-1174. PubMed ID: 35949214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
    Gullo I; Carneiro F; Oliveira C; Almeida GM
    Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on gastric cancer. New molecular classifications].
    Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Fernández Aceñero MJ
    Rev Esp Patol; 2021; 54(2):102-113. PubMed ID: 33726886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
    Popiela T; Kulig J; Kołodziejczyk P;
    Przegl Lek; 2000; 57 Suppl 5():9-13. PubMed ID: 11202309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren's and Goseki's classifications].
    Guglielmi A; de Manzoni G; Tomezzoli A; Ricci F; Pelosi G; Laterza E; Di Leo A; Bonfiglio M
    Chir Ital; 1997; 49(3):45-9. PubMed ID: 9612652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.
    Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
    Am J Clin Oncol; 2021 Jan; 44(1):1-9. PubMed ID: 33086233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
    Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK
    World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extended Pathohistological Criteria for Assessment of the Long-Term Prognosis of Gastric Cancer].
    Dittmar Y; Rauchfuss F; Dondorf F; Ardelt M; Scheuerlein H; Settmacher U
    Zentralbl Chir; 2016 Aug; 141(4):433-41. PubMed ID: 25723861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
    Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
    Laeknabladid; 2016 Mar; 102(3):125-30. PubMed ID: 26985590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
    Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.
    Cisło M; Filip AA; Arnold Offerhaus GJ; Ciseł B; Rawicz-Pruszyński K; Skierucha M; Polkowski WP
    Oncotarget; 2018 Apr; 9(27):19427-19442. PubMed ID: 29721214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer.
    Tu L; Xu J; Wang M; Zhao WY; Zhang ZZ; Zhu CC; Tang DF; Zhang YQ; Wang DH; Zuo J; Cao H
    Tumour Biol; 2016 Jul; 37(7):8775-82. PubMed ID: 26743780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
    Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
    Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison and applicability of molecular classifications for gastric cancer.
    Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
    Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.